A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA.
Lin J, Zhan T, Duffy D, Hoffman-Censits J, Kilpatrick D, Trabulsi EJ, Lallas CD, Chervoneva I, Limentani K, Kennedy B, Kessler S, Gomella L, Antonarakis ES, Carducci MA, Force T, Kelly WK.
Lin J, et al.
Am J Cancer Ther Pharmacol. 2014 Sep 7;2(1):21-32.
Am J Cancer Ther Pharmacol. 2014.
PMID: 25580468
Free PMC article.